BRD4 and cancer: Since we found that Ovcar4 cells overexpressing BRD4 isoforms are particularly sensitive to paclitaxel, we then investigated if combination of paclitaxel and other anti-cancer compounds can enhance the antitumor effect even further (Figure 5G–5I).